PROGRAM CHAIRRobert F. Kushner, MD, MS Professor Emeritus of Medicine, Division of Endocrinology, Metabolism and Molecular Medicine Northwestern University Feinberg School of Medicine Chicago, ILSTATEMENT OF INDEPENDENCE
As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s peer reviewers.
DISCLOSURE POLICY
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.
The Endocrine Society has reviewed these relationships to determine which are relevant to the content of this activity and resolved any identified conflicts of interest for these individuals.
The faculty reported the following relevant financial relationship(s) during the content development process for this activity:
Robert F. Kushner, MD, MS: Novo Nordisk, Advisory Board; Weight Watchers, Advisory Board; Lilly, Advisory Board; Boehringer Ingelheim, Advisory Board; Antag, Advisory Board; AstraZeneca, Advisory Board; AbbVie Advisory Board; Currax Advisory Board; Structure Advisory Board; Viking Advisory Board
The following Special Programs Committee member who planned and reviewed content for this activity reported the following relevant financial relationship(s) during the content development process for this activity:
Dr. Paulo Augusto Miranda, MD PhD: Brazilian Society of Endocrinology and Metabolism, Former President and Member of International Committee; Recordati, speaker, consultant; Ipsen, speaker, consultant; Eli Lilly, speaker, consultant; Novo Nordisk, speaker, consultant.
The Endocrine Society staff involved in the development of this CME activity reported no relevant financial relationships.The Endocrine Society staff have reviewed all disclosures and resolved or managed all relevant identified conflicts of interest, as applicable.ACKNOWLEDGMENT OF COMMERCIAL SUPPORTThis educational activity is supported by educational grants from Eli Lilly and AstraZeneca.
Managed by the Endocrine Society and the Nucleus Group Holdings, Inc.